Tyrosine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S253120, C544S121000, C544S365000

Reexamination Certificate

active

11289834

ABSTRACT:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.

REFERENCES:
patent: 5650415 (1997-07-01), Tang et al.
patent: 6069143 (2000-05-01), Ali et al.
patent: 6099851 (2000-08-01), Weisman et al.
patent: 0 385 850 (2000-09-01), None
patent: WO 99/60023 (1999-11-01), None
patent: WO 00/02871 (2000-01-01), None
patent: WO 00/08202 (2000-02-01), None
patent: WO 00/12089 (2000-03-01), None
patent: WO 00/17203 (2000-03-01), None
patent: WO 00/20023 (2000-04-01), None
patent: WO 00/23469 (2000-04-01), None
patent: WO 00/35455 (2000-06-01), None
patent: WO 00/53605 (2000-09-01), None
patent: WO 01/17995 (2001-03-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/72751 (2001-10-01), None
Ali et al., STN International, HCAPLUS Database, Accession No. 2000:17476, Reg. No. 193902-45-3 (2007).
Parrizas, et al. (1997) Endocrinology 138: 1427-1433.
Blum, et al. (2000) Biochemistry 39:15705-15712.
Gungor, et al. (1992( J. Med. Chem. 35:4455-4463.
Chimirri et al., Heterocycles, vol. 53, No. 3, pp. 613-620, 2000.
Nawwar et al., Chemical Abstract No. 164052r, vol. 120, No. 13, Mar. 28, 1994.
Pednekar et al., Chemical Abstract No. 182731b, vol. 96, No. 22, May 31, 1982.
Sahal, et al. (1988) Archives of Biochemistry and Biophysics 260:416-426.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3775025

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.